Fmr

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
12,917
Total Value
1304366597427
Accession Number
0000315066-25-001380
Form Type
13F-HR
CIK
fmr
Manager Name
Fmr
Data Enrichment
84% identified
10,850 identified2,067 unidentified

Holdings

12,917 positions • $1.3T total value
Manager:
Search and click to pin securities to the top
Page 257 of 265
307359885
Shares:89
Value:$101
% of Portfolio:0.0% ($101/$1.3T)
BlackRock 2037 Municipal Target Term Trust
Shares:4
Value:$101
% of Portfolio:0.0% ($101/$1.3T)
46137V688
Shares:1
Value:$100
% of Portfolio:0.0% ($100/$1.3T)
233051135
Shares:1
Value:$99
% of Portfolio:0.0% ($99/$1.3T)
New Gold Inc. /FI
Shares:25
Value:$92
% of Portfolio:0.0% ($92/$1.3T)
46138E180
Shares:1
Value:$92
% of Portfolio:0.0% ($92/$1.3T)
MANHATTAN BRIDGE CAPITAL, INC
Shares:15
Value:$89
% of Portfolio:0.0% ($89/$1.3T)
33740F805
Shares:2
Value:$88
% of Portfolio:0.0% ($88/$1.3T)
09290C863
Shares:3
Value:$86
% of Portfolio:0.0% ($86/$1.3T)
SONO TEK CORP
Shares:23
Value:$84
% of Portfolio:0.0% ($84/$1.3T)
NRX Pharmaceuticals, Inc.
Shares:37
Value:$76
% of Portfolio:0.0% ($76/$1.3T)
46090A721
Shares:3
Value:$76
% of Portfolio:0.0% ($76/$1.3T)
RAND CAPITAL CORP
Shares:4
Value:$75
% of Portfolio:0.0% ($75/$1.3T)
Intellicheck, Inc.
Shares:23
Value:$70
% of Portfolio:0.0% ($70/$1.3T)
61774R205
Shares:1
Value:$69
% of Portfolio:0.0% ($69/$1.3T)
61774R304
Shares:1
Value:$67
% of Portfolio:0.0% ($67/$1.3T)
Quince Therapeutics, Inc.
Shares:50
Value:$67
% of Portfolio:0.0% ($67/$1.3T)
46138G201
Shares:1
Value:$67
% of Portfolio:0.0% ($67/$1.3T)
61774R502
Shares:1
Value:$65
% of Portfolio:0.0% ($65/$1.3T)
97717X784
Shares:1
Value:$65
% of Portfolio:0.0% ($65/$1.3T)